Suppr超能文献

微波消融联合经皮椎体成形术治疗多节段脊柱转移瘤的安全性和临床疗效。

Safety and clinical efficacy of microwave ablation combined with percutaneous vertebroplasty in the treatment of multisegmental spinal metastases.

机构信息

Department of Oncology Intervention, Central Hospital Affiliated to Shandong First Medical University, 105 Jiefang Road, Jinan, Shangdong Province, China.

出版信息

J Cancer Res Ther. 2024 Apr 1;20(2):712-717. doi: 10.4103/jcrt.jcrt_558_23. Epub 2024 Apr 30.

Abstract

OBJECTIVE

To evaluate the safety and efficacy of microwave ablation (MWA) combined with percutaneous vertebroplasty (PVP) in the treatment of multisegmental (2-3 segments) osteolytic spinal metastases.

MATERIALS AND METHODS

This study comprised a retrospective analysis of data from 20 patients with multisegmental (2-3 segments) osteolytic spinal metastases who received MWA combined with PVP. The visual analog scale (VAS) score, Oswestry Disability Index (ODI) score, Quality of Life Questionnaire-Bone Metastases 22 (QLQ-BM22), and local recurrence before and after the operation were measured. The occurrence of complications was observed to evaluate safety.

RESULTS

All operations were completed successfully with no serious complications. Transient nerve injury occurred in two cases, but recovered after symptomatic treatment. The bone cement leakage rate was 13.9% (6/43). The mean baseline VAS scores were 7.25 ± 0.91 before treatment and 7.25 ± 0.91, 3.70 ± 1.12, 2.70 ± 0.73, 2.40 ± 0.68, 2.25 ± 0.71, and 2.70 ± 0.92 at 1 day, 1 week, 1, 3, and 6 months after treatment; all values were significantly lower (P < 0.001). The mean baseline ODI score decreased from 56.90 ± 9.74 before treatment to 41.90 ± 7.09, 38.10 ± 7.93, and 38.80 ± 10.59 at 1, 3, and 6 months after treatment, respectively; all values were significantly lower (P < 0.001). The average QLQ-BM22 baseline score decreased from 54.10 ± 5.36 before treatment to 44.65 ± 5.22, 43.05 ± 4.78, 42.30 ± 4.06, and 42.15 ± 5.47 at 1 week, 1, 3, and 6 months after treatment; all values were significantly lower (all P < 0.001). The postoperative survival time of all patients was >6 months. In three patients, four vertebral segments recurred 6 months after operation.

CONCLUSION

MWA combined with PVP is a safe and effective treatment for multisegmental osteolytic vertebral metastases that can effectively relieve pain, improve spinal function, improve quality of life, and delay tumor progression. However, it is a long operation, necessitating good preoperative preparation and effective intraoperative pain relief measures.

摘要

目的

评估微波消融(MWA)联合经皮椎体成形术(PVP)治疗多节段(2-3 节段)溶骨性脊柱转移瘤的安全性和疗效。

材料和方法

本研究回顾性分析了 20 例多节段(2-3 节段)溶骨性脊柱转移瘤患者接受 MWA 联合 PVP 治疗的数据。测量手术前后视觉模拟量表(VAS)评分、Oswestry 功能障碍指数(ODI)评分、生活质量问卷-骨转移 22 项(QLQ-BM22)和局部复发情况。观察并发症的发生情况以评估安全性。

结果

所有手术均顺利完成,无严重并发症。2 例出现短暂性神经损伤,但经对症治疗后恢复。骨水泥渗漏率为 13.9%(6/43)。治疗前的平均基线 VAS 评分为 7.25±0.91,治疗后 1 天、1 周、1 个月、3 个月和 6 个月时分别为 7.25±0.91、3.70±1.12、2.70±0.73、2.40±0.68、2.25±0.71 和 2.70±0.92,所有评分均显著降低(P<0.001)。治疗前的平均基线 ODI 评分从 56.90±9.74 降至治疗后 1 个月、3 个月和 6 个月时的 41.90±7.09、38.10±7.93 和 38.80±10.59,所有评分均显著降低(P<0.001)。治疗前的平均基线 QLQ-BM22 评分从 54.10±5.36 降至治疗后 1 周、1 个月、3 个月和 6 个月时的 44.65±5.22、43.05±4.78、42.30±4.06 和 42.15±5.47,所有评分均显著降低(均 P<0.001)。所有患者的术后生存时间均>6 个月。3 例患者在术后 6 个月时出现 4 个椎体节段复发。

结论

MWA 联合 PVP 治疗多节段溶骨性椎体转移瘤是一种安全有效的方法,可有效缓解疼痛,改善脊柱功能,提高生活质量,延缓肿瘤进展。但该手术时间较长,术前需要做好充分准备,术中需要采取有效的止痛措施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验